Clinical trial
Velcade for Proliferative Lupus Nephritis
NCT01169857 is registered in ClinicalTrials.gov with The Rogosin Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Velcade for Proliferative Lupus Nephritis
- Lead sponsor
- The Rogosin Institute
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.